Company: EDSA
Filing Date: 2025-04-04
Form Type: DEF 14A
Source: 0001171843-25-002028
Chunk: 38

Company: Edesa Biotech, Inc.
Filing Date: 2025-04-04
Form: DEF 14A
Chunk 38
---
2024 to employees under the 2019 Plan totaled 500 options to purchase common shares at an exercise price of $4.10. Options granted during the year ended September 30, 2023 to directors, officers and employees under the 2019 Plan totaled 118,579 options to purchase common shares at exercise prices ranging from $5.79 to $10.01. There were 46,602 RSUs granted during the year ended September 30, 2024. There were 46,602 RSUs granted during the year ended September 30, 2023. All RSUs were immediately vested and were for payment of salary, bonuses or consulting fees to the certain members of the executive team.

Options Vesting Policy

Vesting requirements for option awards are determined by the independent members of the Board. Options granted by the Company during the year ended September 30, 2024 and 2023 generally had monthly vesting for directors in equal proportions over 12 months beginning on the grant date, monthly vesting for officers and current employees in equal proportions over 36 months beginning on the grant date and monthly vesting for new employees in equal proportions over 36 months beginning on the monthly anniversary of the grant date following 90 days of employment.

Policies and Practices Related to Grants of Share Options or Similar Awards

<div align='center'>22</div>

PAY VERSUS PERFORMANCE

Pay Versus Performance Table

We are providing the following information about the relationship between executive compensation actually paid and certain financial performance of our company as required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K.

|      | Year |   | Summary Compensation Table Total for Principal Executive officer (“PEO”) (1) |     |   | Compensation Actually Paid to PEO (2) |   |     |   | Average Summary Compensation Table Total for Non-PEO Named Executive Officers (“NEOs”) (3) |     |   | Average Compensation Actually Paid to Non-PEO NEOs (2) |   |     |   | Value of Initial Fixed $100 Investment Based on Total Shareholder Return (“TSR”) (4) |     |   | Net Income (Loss) 
 (millions) (5)    |   |
|:-----|:-----|:--|-----------------------------------------------------------------------------:|:----|:--|--------------------------------------:|:--|:----|:--|-------------------------------------------------------------------------------------------:|